ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,351Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1442

$1.25M Total Retail Price of All Prescriptions

Rank: 13 out of 1442

876 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 876 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

4% of this provider’s 876 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 12,755 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 835 751 1 2
LEVOTHYROXINE SODIUM 488 453 2 22
ATORVASTATIN CALCIUM 406 367 3 4
OMEPRAZOLE 399 372 4 21
ZOLPIDEM TARTRATE 391 315 5 25
LOSARTAN POTASSIUM 325 299 6 13
AMLODIPINE BESYLATE 274 267 7 3
FUROSEMIDE 264 258 8 5
METOPROLOL TARTRATE 256 244 9 6
DIOVAN 240 212 10 19
ATENOLOL 221 195 11 11
METOPROLOL SUCCINATE 215 200 12 1
METFORMIN HCL 190 175 13 26
WARFARIN SODIUM 178 158 14 9
LEVOFLOXACIN 173 141 15 149
METFORMIN HCL ER 173 163 15 71
CARVEDILOL 172 157 17 8
CRESTOR 155 115 18 10
CLOPIDOGREL 154 148 19 12
NEXIUM 148 136 20 34
PRAVASTATIN SODIUM 148 142 20 20
LISINOPRIL 145 144 22 7
DILTIAZEM 24HR ER 140 136 23 36
LOSARTAN-HYDROCHLOROTHIAZIDE 139 132 24 30
CITALOPRAM HBR 137 126 25 81
TAMSULOSIN HCL 135 134 26 38
PLAVIX 134 130 27 14
HYDROCHLOROTHIAZIDE 126 114 28 16
SERTRALINE HCL 123 108 29 58
PREDNISONE 123 90 29 111
RAMIPRIL 105 99 31 18
GABAPENTIN 104 104 32 55
SYNTHROID 102 98 33 40
PANTOPRAZOLE SODIUM 100 86 34 63
ENALAPRIL MALEATE 100 99 34 23
FINASTERIDE 99 99 36 87
BENAZEPRIL HCL 96 92 37 88
PAROXETINE HCL 96 84 37 162
ZETIA 88 74 39 31
ADVAIR DISKUS 88 77 39 79
ESCITALOPRAM OXALATE 86 86 41 150
LIPITOR 83 79 42 24
TRIAMTERENE-HCTZ 81 79 43 50
GLIPIZIDE ER 81 72 43 161
QUINAPRIL HCL 77 77 45 42
HYDROCODONE-ACETAMINOPHEN 76 45 S3 46 84
DIOVAN HCT 74 70 47 35
SPIRIVA 74 74 47 95
LOVASTATIN 74 74 47 53
GLIMEPIRIDE 74 71 47 67
ALENDRONATE SODIUM 72 54 51 46
GLYBURIDE 69 69 R 52 105
NAMENDA 69 69 52 91
JANUMET 69 69 52 109
PROAIR HFA 67 50 55 123
FENOFIBRATE 67 64 55 82
DONEPEZIL HCL 66 66 57 62
AZITHROMYCIN 65 57 58 56
FAMOTIDINE 64 63 59 70
CIPROFLOXACIN HCL 63 58 60 103
OXYCODONE-ACETAMINOPHEN 62 53 S2 61 176
GLIPIZIDE 61 61 62 120
CELEBREX 59 57 63 138
AMITRIPTYLINE HCL 58 27 R 64 259
FLUTICASONE PROPIONATE 57 53 65 99
LANSOPRAZOLE 57 45 65 337
TOPROL XL 56 41 67 51
ISOSORBIDE MONONITRATE ER 56 55 67 17
NYSTATIN-TRIAMCINOLONE 55 54 69 187
ALLOPURINOL 54 48 70 47
MECLIZINE HCL 53 45 71 83
ZOLPIDEM TARTRATE ER 53 34 71 278
BENICAR HCT 53 49 71 86
POTASSIUM CHLORIDE 52 52 74 33
DIGOXIN 52 52 74 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.